TRIL anticorps (C-Term)
-
- Antigène Voir toutes TRIL Anticorps
- TRIL (TLR4 Interactor with Leucine-Rich Repeats (TRIL))
- Épitope
- C-Term
- Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp TRIL est non-conjugé
- Application
- Western Blotting (WB)
- Purification
- Protein A affinity chromatography
- Immunogène
- A recombinant protein fragment from the C-terminal region of human TRIL was used as the immunogen for this antibody.
- Isotype
- IgG
- Top Product
- Discover our top product TRIL Anticorps primaire
-
-
- Indications d'application
-
Western blot: 2-5 μg/mL
Provided assay concentrations are suggestions only, antibody titration may be required for optimal results. - Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 0.5 mg/mL
- Buffer
- PBS with 0.1 mg/mL BSA and 0.05 % sodium azide
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- Aliquot and Store at -20C. Avoid freez-thaw cycles.
-
- Antigène
- TRIL (TLR4 Interactor with Leucine-Rich Repeats (TRIL))
- Autre désignation
- TRIL (TRIL Produits)
- Sujet
- TRIL or TLR4 interactor with leucine rich repeats, is a protein encoded by the human KIAA0644 gene. TRIL protein sequence is highly conserved across species. It is expressed in a number of tissues with highest expression in brain, ovary, small intestine and spleen. TRIL is an accessory molecule that interacts with TLR3 and endosomal TLR4, enhancing their interaction with their ligands, poly(I:C) and LPS, and increasing the production of type I interferons in the innate immune response.
- ID gène
- 9865
- UniProt
- Q7L0X0
- Pathways
- Activation of Innate immune Response, Production of Molecular Mediator of Immune Response
-